Treatment for Esophageal Cancer
The specific treatment that a physician recommends for esophageal cancer will depend on the stage of the cancer and the patient’s overall health, among other factors. After extensively reviewing a patient’s medical history and the specifics of his or her cancer, Moffitt’s multispecialty team will recommend a treatment plan aimed at providing the patient with a favorable outcome and improved quality of life.
Treatment plans may consist of one or more of the following:
- Surgery – Most often, a surgeon will remove the cancerous part of the esophagus (esophagectomy) and then connect the remaining part of the esophagus directly to the stomach.
- Chemotherapy – Drugs are given, either orally or by injection, to kill cancer cells. Moffitt’s medical oncologists give careful consideration to selecting the type and dose of drugs that will maximize the effectiveness of chemotherapy for each individual patient.
- Radiation therapy – High-energy beams are directed at an esophageal tumor with the intention of slowing or stopping the tumor’s growth. Several kinds of radiation therapy are available to patients at Moffitt.
At Moffitt Cancer Center, our patients trust that they are getting the esophageal cancer treatment most appropriate for them, thanks to the collaboration of our multispecialty tumor board. This team meets to discuss every new case and collectively uses their knowledge and skill to develop an individualized treatment plan for each patient. Additionally, as a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt provides patients access to leading-edge treatments through our robust clinical trials program. We also provide a wide range of supportive care services all under one roof to ensure our patients receive the care they need.
To consult with the experts at Moffitt Cancer Center regarding treatment options for esophageal cancer, call 1-888-663-3488 or complete a new patient registration form online. No referral is required.
Esophageal Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer